(NP (NP-COOD (NP (NP (NN Transcription) (NNS factors)) (PP (IN of) (NP (NP-COOD (NP (NN T)) (CC and) (NP (NN B))) (NNS lymphocytes)))) (: --) (NP (NP-COOD (NP (JJ basic) (NN research)) (CC and) (NP (JJ clinical) (NNS perspectives))) (PP (IN for) (NP (NN gastroenterology))))) (. .))
(S (NP-SBJ (NP (ADJP (NN Tissue) (JJ specific)) (NN regulation)) (PP (IN of) (NP (NN gene) (NN expression))) (PP (IN by) (NP (NN transcription) (NNS factors)))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ fascinating) (JJ new) (NN field)) (PP (IN in) (NP (JJ molecular) (NN immunology))))) (. .))
(S (NP-SBJ (DT This) (NN review)) (VP (VBZ summarizes) (NP (NP (NNS data)) (PP (IN on) (NP (NP (JJ specific) (NN regulation)) (PP (IN of) (NP-COOD (NP (NNS promoters)) (CC and) (NP (NNS enhancers)))) (PP (IN by) (NP (NP (JJ nuclear) (JJ trans-acting) (NNS factors)) (PP (IN in) (NP (NNS lymphocytes))))))))) (. .))
(S-COOD (S (NP-SBJ-74 (NP (DT The) (JJ structural) (NNS classes)) (PP (IN of) (NP (NN transcription) (NNS factors)))) (VP (VBP are) (VP (VBN described) (NP (-NONE- *-74))))) (CC and) (S (NP-SBJ-75 (NP (JJ basic) (NNS methods)) (PP (IN for) (NP (NP-COOD (NP (NN detection)) (CC and) (NP (NN analysis))) (PP (IN of) (NP (NN transcription) (NNS factors)))))) (VP (VBP are) (VP (VBN detailed) (NP (-NONE- *-75))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-COOD-77 (NP (NP (DT the) (ADJP (RBS most) (JJ important)) (JJ trans-acting) (NNS factors)) (PP (IN of) (NP (NP (NP-COOD (NP (NN T)) (CC and) (NP (NN B))) (NNS lymphocytes)) (PRN (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (NP-COOD (NP (NN NF-kB)) (, ,) (NP (NN NF-AT)) (CC and) (NP (NN STAT))) (NNS families)) (-RRB- -RRB-))))) (CC and) (NP (PRP$ their) (JJ functional) (NN importance))) (VP (VBP are) (VP (VBN described) (NP (-NONE- *-77)))) (. .))
(S (NP-SBJ-78 (NP (JJ Several) (NNS methods)) (PP (IN for) (NP (NP (JJ specific) (NN down-regulation)) (PP (IN of) (NP (NN transcription) (NNS factors)))))) (VP (VBP are) (VP (VBN shown) (NP (NP (-NONE- *-78)) (SBAR (WHNP-79 (IN that)) (S (NP-SBJ (-NONE- *T*-79)) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ relevant) (PP (TO to) (NP (NP (NN treatment)) (PP (IN of) (NP (JJ human) (NN disease))))))))))))) (. .))
(S (NP-SBJ-80 (DT The) (NNS data)) (VP (VBP are) (VP (VBN discussed) (NP (-NONE- *-80)) (PP (IN with) (NN regard) (TO to) (NP (NP (PRP$ their) (JJ potential) (JJ clinical) (NN relevance)) (PP (IN for) (NP (NN gastroenterology))))))) (. .))
